KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Equity (2016 - 2025)

Historic Return on Equity for Neogenomics (NEO) over the last 16 years, with Q4 2025 value amounting to 0.13%.

  • Neogenomics' Return on Equity fell 400.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.13%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.12% for FY2025, which is 400.0% down from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Return on Equity is 0.13%, which was down 400.0% from 0.13% recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Return on Equity ranged from a high of 0.07% in Q2 2021 and a low of 0.16% during Q3 2022
  • Over the past 5 years, Neogenomics' median Return on Equity value was 0.09% (recorded in 2023), while the average stood at 0.08%.
  • In the last 5 years, Neogenomics' Return on Equity soared by 800bps in 2021 and then tumbled by -2100bps in 2022.
  • Neogenomics' Return on Equity (Quarter) stood at 0.01% in 2021, then crashed by -1829bps to 0.14% in 2022, then surged by 35bps to 0.09% in 2023, then rose by 7bps to 0.09% in 2024, then plummeted by -48bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q4 2025, 0.13% for Q3 2025, and 0.12% during Q2 2025.